Robert R Ruffolo is a director of Elicio Therapeutics Inc.
Person profile
Roles
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Elicio Therapeutics, Inc.
29 Dec 23
4
Sigilon Therapeutics, Inc.
11 Aug 23
3
Elicio Therapeutics, Inc.
7 Jun 23
4
Sigilon Therapeutics, Inc.
22 May 23
4
Aridis Pharmaceuticals, Inc.
7 Dec 22
4
Sigilon Therapeutics, Inc.
27 May 22
4
Aridis Pharmaceuticals, Inc.
5 Oct 21
4
Sigilon Therapeutics, Inc.
2 Jul 21
4
Sigilon Therapeutics, Inc.
28 Jun 21
4
Sigilon Therapeutics, Inc.
7 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Dec 23 | ELTX Elicio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 4,100 | 33.87 k | 4,100 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.51 | 3,754 | 28.19 k | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.9984 | 683 | 3.41 k | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.6439 | 683 | 4.54 k | 0 |
19 May 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6366 | 8,888 | 5.66 k | 8,888 |
5 Dec 22 | ARDS Aridis Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 10,000 |